ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-DR4 Antibody [B-T35] - BSA and Azide free (A341927)

Mouse monoclonal [B-T35] IVD antibody to DR4 for ELISA.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-DR4 Antibody [B-T35] - BSA and Azide free
Description
Mouse monoclonal [B-T35] IVD antibody to DR4.
Specificity
This product recognizesboth natural and recombinant TRAIL-R1 (DR4), a 43-46 kDa protein.
Applications
ELISA
Reactivity
Human
Immunogen
Recombinant human TRAIL R1/Fc chimera.
Host
Mouse
Clonality
Monoclonal
Clone ID
B-T35
Myeloma
Source: Myeloma X63/AG.8653 x Balb/c spleen cells
Isotype
Mouse IgG1 Kappa light chain
Conjugate

Unconjugated

Concentration
1.0 mg/mL (+/- 10 %)
Product Form
Liquid
Formulation
Phosphate-buffered saline. Sterile-filtered through 0.22µm. Carrier and preservative free.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
APO2, CD261, Death receptor 4, TNF-related apoptosis-inducing ligand receptor 1, TNFRSF10A, TRAIL receptor 1, TRAIL-R1, TRAILR1, Tumor necrosis factor receptor superfamily member 10A
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-DR4 Antibody [B-T35] - BSA and Azide free (A341927)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-DR4 Antibody [B-T35] - BSA and Azide free (A341927)

Proteins predicted to interact with DR4

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
99.7% Relevancy Score
99.7% Relevancy Score
99.5% Relevancy Score
99% Relevancy Score